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Stuttgart, GermanyABSTRACT Supported lipid bilayers (SLBs) are popular models of cell membranes. Owing to the importance of glycosphin-
golipids (GSLs) in modulating structure and function of membranes and membrane proteins, methods to tune the GSL content
in SLBs would be desirable. Glycolipid transfer protein (GLTP) can selectively transfer GSLs between membrane compart-
ments. Using the ganglioside GM1 as a model GSL, and two mass-sensitive and label-free characterization techniques—quartz
crystal microbalance with dissipation monitoring and ellipsometry—we demonstrate that GLTP is an efficient and robust
biochemical tool to dynamically modulate the GSL content of SLBs up to 10 mol % GM1, and to quantitatively control the
GSL content in the bulk-facing SLB leaflet. By exploiting what we believe to be a novel tool, we provide evidence that GM1
distributes highly asymmetrically in silica-supported lipid bilayers, with ~85% of the ganglioside being present in the bulk-facing
membrane leaflet. We report also that the pentameric B-subunit of cholera toxin binds with close-to-maximal stoichiometry to
GM1 in SLBs over a large range of GM1 concentrations. Furthermore, we quantify the liganding affinity of GLTP for GM1 in
an SLB context to be 1.5 mM.INTRODUCTIONSupported lipid bilayers (SLBs) have become very popular
as models of cell membranes with potential biotechnolog-
ical applications (1–4). They have provided insight into
a plethora of membrane processes from the molecular to
the cellular scale, including lipid domain formation and
dynamics (5–8), protein adsorption and self-assembly at
lipid membranes (9,10), intermembrane interactions (11),
and juxtacrine signaling (12,13).
The interest in confining lipid membranes on surfaces has
been driven by the emergence of amultitude of surface-sensi-
tive characterization techniques, and the possibility to
spatially control membrane deposition (14–16), composition
(17), and shape (18,19). The confinement to a macroscopic
surface is also attractive from a practical point of view: the
adjacent aqueous solution can be readily exchanged and
membranes sequentially incubated with different sample
solutions without the need of elaborate separation steps
that are typically required for vesicles in solution, thus facil-
itating both the biochemical modification of membranes and
functional studies.
Glycosphingolipids (GSLs) represent a small (typically
5–10 weight %) but functionally important fraction of
membrane lipids in eukaryotes (20). They provide the
plasma membrane with mechanical stability, and take part
in fundamental biological processes including cell differen-
tiation, cell-cell interaction, and transmembrane signaling.
GSLs are enriched in liquid-ordered membrane microdo-
mains which putatively function as organization sites forSubmitted June 14, 2010, and accepted for publication September 8, 2010.
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0006-3495/10/11/2947/10 $2.00signaling proteins. GSL trafficking, accumulation, or cluster
formation has been associated with many pathological
conditions, including autoimmune disorders and neurode-
generative diseases (21).
In functional studies, it would be desirable that the compo-
sition of model membranes can be tightly controlled and
dynamically modulated. The overall lipid composition of
SLBs can be varied with relative ease, e.g., by adjusting the
mixing ratio of lipids in the liposomes if the SLB is formed
by the method of vesicle spreading (3). Attractive or repul-
sive interactions of some lipid types with the underlying
support, though, do often lead to an asymmetric distribution
of lipids between the two membrane leaflets (3,22–25). The
exact lipid composition in the bulk-facing SLB leaflet is
hencemore difficult to control. Notably, it has hitherto hardly
been possible to dynamically modulate the lipid composition
of existing SLBs in a controlled way (26–30). Methyl-b-
cyclodextrin has become popular as a shuttle for the insertion
or extraction of cholesterol (31,32), another functionally
important membrane component that profoundly affects
lipid ordering and domain formation. Similarmolecular tools
for the enrichment or depletion of lipid bilayers with
a selected lipid type would be very attractive.
GLTP is a soluble 24 kDa protein with a pI of ~9.0 that
specifically promotes intermembrane transfer of sphingoid-
and glycerol-based glycosphingolipids in which the first
sugar residue is b-linked to the hydrophobic lipid moiety
(33). In vitro assays with lipid vesicles (34–36) and structural
studies (37,38) have led to the transfer model (see Fig. S1 in
theSupportingMaterial) inwhichGLTPfirst extracts a glyco-
sphingolipid molecule via transient interaction with the
donor membrane. GLTP recognizes the sugar head anddoi: 10.1016/j.bpj.2010.09.016
2948 Carton et al.encapsulates one or both lipid tails within its hydrophobic
interior to forma complex,which then can diffuse in solution.
The liganding affinity ofGLTP for double-chainedGSLswas
found to be in the lower mMrange (36). A transient encounter
with an acceptor membrane eventually leads to lipid release
and terminates the transfer.
The objective of this study was to evaluate the potential of
GLTP as a tool to modulate the GSL content of SLBs. To
this end, we employed the ganglioside GM1 and phosphati-
dylcholine (PC) as model GSL and inert lipid, respectively.
Two mass-sensitive and label-free characterization tech-
niques, i.e., quartz crystal microbalance with dissipation
monitoring (QCM-D) and ellipsometry, were used to
monitor the formation of SLBs and the transfer activity of
GLTP. The specific recognition of GM1 by the B-subunit
of cholera toxin was exploited to quantify the amount of
the ganglioside in the bulk-facing SLB leaflet.
This approach allowed us to quantify the interleaflet
distribution of GM1 in SLBs and the stoichiometry of the
multivalent interaction between GM1 and cholera toxin B
subunit. Our results also provide a quantification of the li-
ganding affinity of GLTP for GM1 and GM1 insertion/
extraction rates in the SLB context.MATERIALS AND METHODS
Buffers
AHEPES buffer solution of 150mMNaCl, 10mMHEPES, and 3mMNaN3
at pH 7.4 was prepared in ultrapure water (resistivity 18.2 MU/cm). A
quantity of 2 mM CaCl2 was added for the formation of SLBs. A quantity
of 2 mM EDTAwas added for all other incubation steps.Vesicle preparation
Lyophilized 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and GM1
ganglioside (GM1) were purchased from Avanti Polar Lipids (Alabaster,
AL). Pure DOPC and mixtures of DOPC and GM1 at different molar ratios
were dissolved in chloroform and an equivolume mixture of chloroform and
methanol, respectively, then dried, resuspended in HEPES buffer, and
homogenized as described earlier (39). Small unilamellar vesicles
(SUVs) were obtained by sonication (40). Extruded unilamellar vesicles
(EUVs) were obtained by extrusion through polycarbonate membranes
with 100 nm pore size (LiposoFast; Avestin Europe, Weinheim, Germany).
The vesicle suspensions of ~2 mg/mL concentration were stored at 4C
under nitrogen, and diluted to desired concentrations before use. Lipid
concentrations and mixing ratios were deduced from the mass of lipids dis-
solved within an error of less than510%.Proteins GLTP and CTB5
Glycolipid transfer protein (GLTP; molecular mass 24 kDa) was expressed
and purified as described earlier (37,38). The stock solution of ~10 mg/mL
was diluted in 20 mM TRIS (pH 7.4) and 150 mM NaCl to 2 mg/mL and
aliquots were stored at 80C. The protein was verified to be functional
by fluorescence binding (36) and crystallization (37,38) assays. The protein
concentration was determined by optical density measurements (Nanodrop
2000; Thermo Scientific, Wilmington, DE) at a wavelength of 280 nm using
an extinction coefficient of 0.79 g1$L$cm1. Lyophilized cholera toxin
B-subunit pentamer (CTB5, 58 kDa) (Sigma, St. Louis, MO) was reconsti-Biophysical Journal 99(9) 2947–2956tuted in ultrapure water at a stock concentration of ~1 mg/mL, and stored at
4C. Before use, protein stock solutions were diluted in EDTA-containing
HEPES buffer to the desired concentration.Substrates
Silica-coated QCM-D sensors (QSX303; Q-Sense, Va¨stra Fro¨lunda,
Sweden) were immersed in an aqueous solution of 2% sodium dodecyl
sulfate for 30 min, rinsed abundantly with ultrapure water, blow-dried
with N2, treated with UV/ozone (Bioforce Nanoscience, Ames, IA) for
30 min, and placed in the measurement chambers.Quartz crystal microbalance with dissipation
monitoring
Quartz crystal microbalance with dissipation monitoring (QCM-D)
measures changes in resonance frequency (Df) and dissipation (DD) of
a sensor crystal upon interaction of (soft) matter with its surface. The
QCM-D response is sensitive to the mass (including coupled solvent) and
the mechanical properties of the surface-bound layer. Measurements were
performed with a Q-Sense E4 system (Q-Sense, Va¨stra Fro¨lunda, Sweden),
at a working temperature of 23C. Unless otherwise stated, the system was
operated in flow mode, with a rate of typically 20 mL/min. For quantitative
interaction assays between GLTP and GM1, a purpose-designed fluid
handling method was developed (see the Supporting Material). Df and
DD were measured at six overtones simultaneously; changes in dissipation
and normalized frequency, Df ¼ Dfi/i, of the ninth overtone (i ¼ 9) are
presented.
Quantification of adsorbed masses
The ‘‘acoustic’’ mass, mQCM,, was calculated according to mQCM ¼
C Df ;with C ¼ 18:0650:15 ng$cm2$Hz1for the sensors used here.
This equation is valid for films that exhibit low dissipation, as is the case
for CTB5 or SLBs, but includes hydrodynamically coupled solvent. To
account for the contribution of solvent to the QCM-D response, calibration
measurements with an in situ combination of QCM-D and ellipsometry on
the same support were performed (see the Supporting Material).RESULTS
Insertion of GM1 into SLBs
To study the efficiency of GLTP to transfer GM1 from vesi-
cles to supported lipid bilayers (SLBs), the following assay
was designed (Fig. S1). First, an SLB was formed by
spreading of small unilamellar vesicles (SUVs) made of
DOPC to a silica surface. Second, selected test solutions
containing GLTP and/or GM1 in various presentations
were exposed to the SLB. Third, cholera toxin B-subunit
was added to determine the amount of accessible GM1 in
the SLB. All steps were monitored by QCM-D (Fig. 1).
Exposure of DOPC SUVs to silica (Fig. 1 A) resulted in
a two-phase behavior in both frequency and dissipation,
with final changes, Df ¼ 25 Hz and DD < 0.3  106.
This response is characteristic for the formation of an
SLB of good quality (41).
Small but detectable and fast changes of Df ¼ 2 Hz and
DD¼ 0.15 106 occurred upon continuous exposure of the
SLB to a solution of 50 mg/mL vesicles containing 5 mol %
(3.0 mM) GM1 together with 2.1 mM GLTP (Fig. 1 B). No
FIGURE 1 Assay for the insertion of GM1 into SLBs, monitored by
QCM-D. (A) Formation of an SLB upon exposure of 50 mg/mL DOPC
SUVs to a silica-coated sensor surface. (B) Exposure of different donor solu-
tions in flowmode to the SLB:mixture of 2.1mMGLTPand 50mg/mLSUVs
containing 5 mol % (¼ 3.0 mM) GM1 (-B-), 50 mg/mL SUVs containing
5 mol % GM1 alone (-7-), 2.1 mM GLTP alone (->-), micellar solutions
of GM1 at concentrations of 32 mM(-D-) and 640mM(-,-), and pure buffer
solution (-). (C) Subsequent incubation of 0.17 mMCTB5. Each incubation
step starts at 0 min; rinses in buffer are indicated (arrowheads).
FIGURE 2 Assay for the extraction of GM1 from SLBs, monitored by
QCM-D. (A) Formation of an SLB upon exposure of 50 mg/mL SUVs con-
taining 5 mol % GM1 to a silica-coated sensor surface. (B) Exposure of
different acceptor solutions in flow mode to the SLB: mixture of 2.1 mM
GLTP and 50 mg/mL DOPC SUVs (-B-), 2.1 mM GLTP alone (->-),
50 mg/mL DOPC SUVs alone (-7-), and pure buffer solution (--). (C)
Subsequent incubation of 0.17 mM CTB5. Each incubation step starts at
0 min; rinses in buffer are indicated (arrowheads).
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nents alone. Neither did we observe any response when
presenting pure GM1, in the form of micellar solutions, to
the SLB; even a >200-fold increase in the GM1 concentra-
tion (640 mM), as compared to the SUVs, did not produce
any significant frequency shift. These results provide a first
indication for GLTP-mediated transfer of GM1 to SLBs.
From the frequency response upon transfer, we estimate an
apparent initial insertion rate of 10 Hz/min. Also, the
QCM-D response upon transfer reached 80%of its final value
within 30 s, indicating that insertion is fast.
It is remarkable that exposure of GLTP in mM concentra-
tions to DOPC SLBs did not result in any measurable QCM-
D response. Neither did we find any unbinding when rinsing
after exposure of GLTP and GM1-containing vesicles that
would have been indicative for the transient presence of
GLTP at the membrane. Apparently, GLTP does not bind
with appreciable affinity to SLBs irrespective of their
GM1 content. The interaction that leads to GM1 transfer,
therefore, must be short-lived.
The direct QCM-D response upon GM1 transfer remained
rather small. This limits the quantification of transfer, and
minor transfer may potentially remain undetected. CTB5
was used to enhance the signal for the presence of GM1 in
the SLB (Fig. 1 C). Strongest binding (Df ¼ 10.5 Hz)
was observed on SLBs that were incubated with GM1-con-
taining SUVs and GLTP, corroborating successful transfer.
CTB5 remained stably bound upon rinsing in buffer, and
changes in dissipation remained small (DD < 0.5  106)
throughout the adsorption process, indicating that CTB5associated tightly to the SLB (42). No bindingwas detectable
on SLBs that were not exposed to GM1, confirming that
CTB5 binding was specific. CTB5 binding was very small
(jDfj< 1Hz) on SLBs that were exposed to SUVs containing
3.0 mMGM1, or to 32 mMof GM1micelles in the absence of
GLTP. However, some binding (Df ¼ 4 Hz) was observed
after incubation with large concentrations (640 mM) of
micellar GM1 solutions, indicating that some spontaneous
insertion does also occur.
These data provide evidence that GLTP can efficiently
transfer GM1 from vesicles to SLBs. The transfer is faster,
by several orders of magnitude, than the spontaneous inser-
tion of GM1 from vesicular or micellar solutions in the
absence of GLTP.Extraction of GM1 from SLBs
In the next step, we tested whether GLTP is able to extract
GM1 from SLBs. For this purpose, GM1-containing SLBs
were formed from SUVs that were made of a mixture of
DOPC and 5 mol % GM1 (Fig. 2 A). The SLBs were then
exposed to a continuous flow of solutions of GLTP and/or
SUVs containing only DOPC. The concentrations of
GLTP and SUVs were kept identical to the insertion assay.
Incubation with a mixture of GLTP and acceptor SUVs
for 10 min induced an increase in Df, indicating removal
of lipid material from the SLB. The value DD remained
unchanged (Fig. 2 B), indicating that the SLB remained
intact, i.e., without large-scale defects that would likely
have promoted adhesion of acceptor SUVs. Subsequent
addition of CTB5 (Fig. 2 C) resulted in Df ¼ 3.5 Hz,Biophysical Journal 99(9) 2947–2956
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ing SLBs. Prolonged incubation with GLTP and DOPC
SUVs for 30 min decreased the CTB5-induced absolute
frequency shifts below 1.0 Hz (data not shown). In contrast,
no changes were observed upon incubation of DOPC SUVs
alone (Fig. 2, B and C). Neither did we observe any changes
in the apparent GM1 content when flushing the SLB over-
night with buffer solution (data not shown). This provides
evidence that most accessible GM1 can be removed from
the SLB and that it is the GLTP that extracts GM1. The
apparent initial extraction rate was 0.5 Hz/min, or 20-fold
lower than the initial rate of insertion under equivalent
conditions. It also took much longer, ~8 min, to reach
80% of the maximal response for extraction, as compared
to 30 s for insertion.
The presence of acceptor vesicles was not required for the
extraction of GM1 from SLBs: efficient extraction occurred
even in the presence of GLTP alone (Fig. 2, B and C). In
fact, the extraction kinetics were hardly affected by the
absence of donor vesicles, indicating that extraction of
GM1 is the rate-limiting step in GLTP-mediated transfer
of GM1 from SLBs to acceptor vesicles.
Moreover, insertion and extraction of GM1 could be
cycled several times, by alternately exposing SLBs for
10 min to a mixture of GLTP and SUVs containing 5 mol
% GM1, and to GLTP alone. After each addition of the
GLTP/SUV mixture, CTB5-induced frequency shifts
of 10 5 1 Hz were obtained, whereas only 2 5 1 Hz
were found after exposure to GLTP alone (two full cycles
were tested; data not shown).
After a qualitative investigation of the propensity of
GLTP to modulate the composition of SLBs, further detailed
studies were performed to better understand the interaction
between GM1 and GLTP. To this end, we first had to estab-
lish that CTB5 can serve as a quantitative marker for the
amount of accessible GM1.CTB5 as a quantitative marker for accessible GM1
The B-subunits of cholera toxin are assembled into a pen-
tamer with fivefold axial symmetry, and upon binding to lipid
membranes, each subunit in the pentamer can interact specif-
ically with oneGM1molecule (43,44). To test whether CTB5
binds stoichiometrically to GM1, we prepared SLBs contain-
ing various molar proportions of GM1. To this end, wemixed
SUVs from two different stock solutions, one containing pure
DOPC and the other ~5mol %GM1, at controlled ratios, and
exposed the resulting solutions to silica surfaces. The
approach of mixing two vesicular solutions of different
composition, rather than preparing a range of SUV stock
solutions with varying GM1 content, was chosen because pi-
petting of buffer-suspended vesicles is more accurate and
simpler than the mixing of lipids that are dissolved in rapidly
evaporating organic solvents. In addition, SLBs were also
prepared from an SUV solution containing 10 mol % GM1.Biophysical Journal 99(9) 2947–2956SLBs could be successfully formed with all nominal GM1
concentrations (data not shown). The absolute final
frequency shifts for SLBs containing GM1 were slightly
higher than for pure DOPC SLBs. An increase in the molar
proportion of GM1 in the SUVs, from 0 to 10%, correlated
with an increase in jDfj, from25 to 32Hz. The additional shift
of 7 Hz indicates an increase in the thickness of the SLB, by
~1 nm. The increased size of the carbohydrate-bearing GM1
headgroups as compared to PC is consistent with such
a scenario. An alternative explanation for the increased
frequency shift would be the presence of residual vesicles
in the SLB, i.e., a decreasing SLB quality. Such vesicles,
however, would also induce an increase in the dissipation
shift. In our experiments, we did not observe a systematic
change in DD. Instead, the dissipation remained small
(DD < 0.5  106), indicating that the number of residual
vesicles that are embedded in the SLB is low.
The open squares in Fig. 3 A show the adsorbed amount
of CTB5, derived from QCM-D frequency shifts, as a func-
tion of the molar proportion of GM1 in the SUVs that were
used for the formation of SLBs. Independent of the GM1
proportion, CTB5 bound irreversibly and binding did not
depend significantly on CTB5 concentration within the
tested range (0.04–1.6 mM). The adsorbed amounts
increased monotonously with the molar proportion of
GM1. The relationship, however, was not linear. This is
not surprising if one considers that the mass measured by
QCM-D includes a substantial amount of coupled solvent,
and that the relative contribution of trapped water to the
frequency response can change with coverage (45,46). After
correcting the QCM-D data for the contribution of coupled
solvent (open circles in Fig. 3 A) with the aid of a calibration
curve that was derived from a combined QCM-D and ellips-
ometry measurement (Fig. S2), we found a close-to-linear
relationship between the nominal molar proportion of
GM1 and the surface density of CTB5, for GM1 proportions
up to 5%. A plateau was reached for higher GM1 contents.
The surface mass density of CTB5 in the plateau regime was
~280 ng/cm2. Assuming hexagonal packing, this would
correspond to an average center-to-center distance between
neighboring CTB5 molecules of 6.3 nm. The lateral exten-
sion of the pentamer is only slightly smaller (6.0 nm)
(43), which readily explains the attenuation of CTB5
binding at nominal GM1 proportions above 5 mol % as
a consequence of steric constraints, i.e., saturation of the
protein monolayer.
Conversion of the adsorbed masses into molar surface
densities (Fig. 3 A) revealed that, for molar GM1 propor-
tions below 5 mol %, only 2.5 GM1 molecules were on
average available per CTB5 pentamer. Two possibilities
appear reasonable to explain this observation. First, an
excess of CTB5 on the surface leads to competition for
GM1, thereby lowering the average occupancy of binding
sites (47). Second, the amount of GM1 that is present in
the bulk-facing SLB leaflet does not correspond to 50% of
FIGURE 3 (A) Stoichiometry of CTB5 binding to GM1 in SLBs. Masses
upon CTB5 binding to SLBs, formed from SUVs as a function of the molar
proportion of GM1 in the SUVs, as obtained by QCM-D (mQCM,,) and
after accounting for the contribution of trapped solvent (mCTB5 , B). The
surface density of GM1 in the SLB was derived from the SUV composition,
assuming an average surface area per lipid of 0.70 nm2 and a symmetric in-
terleaflet lipid distribution. A linear fit (solid line) to the data for mCTB5
reveals a stoichiometry of 2.5:1 between GM1 and CTB5. mCTB5 on
SLBs formed from EUVs of selected GM1 proportions is also shown before
() and after (:) coincubation of 0.8 mM GLTP and 200 mg/mL EUVs of
identical composition as used during SLB formation for 45 min. A linear fit
to the postincubation data gives a stoichiometry of 4.3, indicating close-to-
maximal occupancy of the GM1 binding sites in CTB5 and strong enrich-
ment of GM1 in the bulk facing SLB leaflet before coincubation. (B)
Surface density of GM1 in the SLB after coincubation for 30 min (B)
and 60 min (), respectively, of DOPC SLBs with 0.8 mM GLTP and
200 mg/mL donor EUVs of selected GM1 proportions. The dashed line
corresponds to the surface density in the donor EUVs, i.e., the maximal
Modulating the Glycolipid Content of SLBs 2951the total GM1 content as assumed in the above calculation.
If all gangliosides were instead partitioned in this leaflet, the
stoichiometry would indeed be 5:1.GM1 distribution in SLBs is strongly asymmetric
To test these hypotheses, we devised a coincubation assay
that exploits the glycosphingolipid transfer activity of
GLTP: SLBs were first formed from a given vesicle solution
and then exposed to a mixture of the same vesicle solution
together with GLTP. For this assay, we used extruded unila-
mellar vesicles (EUVs) of 100-nm nominal diameter.
Thanks to the large radius of curvature of EUVs, GM1 is
likely to be distributed symmetrically between the two
membrane leaflets (48–50). Furthermore, the vesicle
concentration was chosen such that GM1 in the vesicles
was in large molar excess with respect to GLTP in solution.
We rationalized that, at equilibrium, the molar proportion of
GM1 in the bulk-facing SLB leaflet should adjust to the
known molar proportion of GM1 in the vesicles.
The amounts of CTB5 that bound to SLBs made from
EUVs containing 1.8, 4, and 5 mol % GM1, respectively,
before and after incubation with the EUV/GLTP mixture
for 45 min are displayed in Fig. 3 A. The preincubation
data (solid circles) matched our earlier observations on
SUV-based SLBs well, indicating that the vesicle source
does not affect the amount of GM1 that is displayed in the
bulk-facing SLB leaflet. After incubation with the EUV/
GLTP mixture, however, CTB5 binding decreased drasti-
cally. The postincubation data could again be fitted with
a straight line, and the resulting stoichiometry was 4.3
GM1 molecules per CTB5 pentamer, close to the maximal
value of 5. Prolonged incubation with EUV/GLTP did not
affect CTB5 binding, confirming that equilibrium was at-
tained.
Our findings imply: i), that about 85% of GM1 must
reside in the bulk-facing SLB leaflet, and ii), that CTB5
binding scales linearly with the amount of accessiblepossible transfer. Error bars represent variations between two measure-
ments and experimental noise. (C) Equilibrium binding of CTB5 to laterally
mobile GM1, according to predictions by Lauer et al. (47), for CTB5 solu-
tion concentrations of 0.17 (thick dash-dotted line), 0.017 (thin dash-dotted
line, D) and 1.7 mM (thin dash-dotted line,7). The model assumes multi-
step binding: the CTB5 pentamer first docks via a single GM1 molecule
onto the membrane and then free binding sites are occupied by additional
GM1 molecules. Equilibrium constants for initial binding and subsequent
surface cross-linking of 1.0 107 mM1 and 1.1 1012 cm2, respectively,
were taken from Lauer et al. (47). At a CTB5 solution concentration of
0.17 mM, which is typical for our binding assays, a stoichiometry of <2
GM1 molecules per CTB5 pentamer would be predicted, and a saturation
of the membrane surface (~5 pmol/cm2) with CTB5 would already be
reached at 3 mol % GM1. Furthermore, adsorbed amounts are predicted
to be highly sensitive to the solution concentration of CTB5. None of these
predictions is reproduced by our data. However, the model would be consis-
tent with our data (gray solid line) if the equilibrium surface cross-linking
constant is increased by four orders of magnitude (dashed lines).
Biophysical Journal 99(9) 2947–2956
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a dynamic range of up to 8 mol % GM1 in the accessible
SLB leaflet (Fig. S3).
Interaction between GLTP and GM1
Our initial assays on the extraction of GM1 from SLBs
(Fig. 2) demonstrated that GLTP alone can efficiently
sequester GM1 from a lipid membrane and maintain it in
the soluble phase. To obtain quantitative insight into the
equilibrium distribution of GM1 between the SLB and
GLTP, selected amounts of GLTP were exposed, in a batch
of still solution, to an SLB that contained a fixed amount of
GM1 (Fig. 4). The amount of GM1 that was extracted at or
close to equilibrium was then quantified indirectly, from theFIGURE 4 Quantitative assay for the interaction between GLTP and
GM1. (A) Step-by-step assembly of the interaction assay, followed by
QCM-D (Df,,; DD,B). Start and duration of all incubation steps is indi-
cated (arrows). SLBs were formed by spreading of 50 mg/mL SUVs
containing 5 mol % GM1 to a silica surface. GLTP of varying concentra-
tions, here [GLTP]tot¼ 6.3 mM, was rapidly injected, incubated in still solu-
tion for 15 min and then rapidly washed out (see the Supporting Material for
details). The total frequency shift upon subsequent incubation of 0.17 mM
CTB5 and a stoichiometry of 4.3 GM1 molecules per CTB5 pentamer were
used to determine [GM1], i.e., the amount of accessible GM1 that remained
in the SLB (Fig. S3). The total concentration of accessible GM1, [GM1]tot,
was fixed at 0.75 mM. (B) The fraction of nonliganded GM1, [GM1]/
[GM1]tot, after the reaction is plotted as a function of the normalized total
concentration of GLTP, [GLTP]tot/[GM1]tot. Error bars represent variations
between two measurements and experimental noise. The fit (solid line) to
a simple interaction model (see Eq. S2 c in the Supporting Material) gives
KD ¼ 1.55 0.4 mM.
Biophysical Journal 99(9) 2947–2956amount of CTB5 that bound to the SLB after rapid removal
of GLTP from the solution.
Fig. 4B provides clear evidence that the extraction ofGM1
is dependent on the amount of free GLTP: upon increasing
the concentration of GLTP in the reaction chamber, CTB5
binding decreased progressively, i.e., the amount of GM1
that was extracted from the SLB and went into the solution
phase increased. Each GLTP molecule can accommodate
a single GSL. Our data could be fitted well by a simplemodel
that describes the extraction ofGM1 from the SLB as an equi-
librium reaction of membrane-bound GM1 and soluble
GLTP into a soluble GM1GLTP complex (see the Support-
ing Material for details). The resulting dissociation constant
was 1.55 0.4 mM.Tuning the GM1 content in SLBs
Our data in Figs. 1 and 2 demonstrated that GLTP can effi-
ciently extract and insert GM1 from SLBs. Can the amount
of GM1 in the SLB be modulated with quantitative control?
The coincubation assay that we used earlier to test
membrane asymmetry illustrates how controlled amounts
of GM1 can be extracted from SLBs. To test whether the
method works equally well to enrich SLBs, we applied the
assay on SLBs that were formed from GM1-free vesicles,
using EUVs of varying GM1 proportion. The total concen-
tration of lipids and GLTP were kept constant, GM1 in the
donor vesicles was used in sufficient excess over GLTP to
avoid significant depletion of the GM1 pool into
GM1GLTP complexes, and the incubation time was fixed
to 30 min.
For %4 mol % GM1 in the donor EUVs, the amount of
accessible GM1 (Fig. 3 B) was in good agreement with
the values that we had found in the extraction assays
(Fig. 3 A). The concentration of accessible GM1 in the
SLB was hence equal to the concentration in the EUVs.
Beyond 4 mol %, however, the surface density in the SLB
remained significantly below that in the EUVs. The amount
of transferred GM1 could be pushed further by increasing
either the concentrations of GLTP or the incubation time.
An incubation time of 60 min, for example, led to maximal
transfer for 5 mol % GM1 in the EUVs, and insertion at or
above the detection limit of 20 pmol/cm2, or 8 mol %, was
observed from EUVs containing 20 mol % GM1 (Fig. 3 B).
Apparently, the incorporation of large amounts of GM1
into the SLB is rather slow. It is remarkable, however, that
amounts as large as 8 mol % can be incorporated into
SLBs at all, if one considers that the incorporation of
GM1 is likely to lead to an increase in lipid packing density
due to the confinement of SLBs to the support. In this
context, it is also notable that the increase in lipid packing
does not seem to influence the equilibrium distribution of
GM1 between the SLB and donor vesicles. One might spec-
ulate that an increased lipid packing could provoke the
expulsion of lipids from the SLB, e.g., in the form of
Modulating the Glycolipid Content of SLBs 2953membrane blebs or tubes. Such soft structures would be
readily detected by the dissipation response. In contrast,
we found that the dissipation shifts remained small (<0.5
 106, data not shown), even upon incorporation of 8
mol % and more GM1, indicating that the SLB retained
its planar morphology.DISCUSSION
We have demonstrated that GLTP can serve as an efficient
and robust modulator of the GM1 content in SLBs. The
GM1 content in the bulk-facing membrane leaflet can be
quantitatively controlled and dynamically cycled by expo-
sure to mixtures of GLTP and vesicles of defined GM1
content. Here, GLTP plays a catalytic role as a carrier that
shuffles gangliosides from one membrane compartment to
another. A net flux of lipids will be maintained until an equi-
librium lipid distribution is attained. Under the employed
experimental conditions, we find that the extraction of
GM1 from SLBs is slower than the insertion.
Owing to its large hydrophilic head, GM1 exhibits higher
solubility thanmost other lipids and readily formsmicelles in
aqueous solution (51). Hence, GM1 may insert spontane-
ously into preformed membranes when presented as a
micellar solution. This has, indeed, been shown (28,52,53),
although the process was rather slow, requiringGM1 concen-
trations of several 100 mM and incubation times of several
hours. In comparison, GLTP-assisted transfer is readily
accomplished with micromolar concentrations of GM1 and
(sub)micromolar concentrations of GLTP within a few
minutes.
GLTP transfers differentGSLswith similar efficiency (36).
Hence, it is very likely that the approach outlined here can be
readily extended to modify the content of model membranes
in other GSL species without affecting their content in other
lipid types. The GSL content in SLBs can, in this way, be
dynamically tuned within the range that is typically covered
by the plasmamembrane of eukaryotes (20). With the advent
of genetically engineered GLTP mutants that are specific for
a particular type of GSL, it may also become possible to
modulate, selectively, the membrane content in specific
GSL species (L. Malinina, unpublished results).
Considering the important role of GSLs in the regulation
of membrane structure and function, and the robustness of
GLTP, the protein has the potential to become a hitherto
unique and invaluable tool to control membrane composi-
tion. In particular, the GSL content in the bulk-facing
membrane leaflet can be precisely controlled and dynami-
cally changed—features that, to our knowledge, are not
readily provided by established SLB preparation techniques.
Such a methodological approach is equivalent to the
established use of b-cyclodextrin as a carrier to modulate
the cholesterol content in membranes (32,54). GLTP has
the added advantage of being very well soluble in aqueous
solution.Mechanism of GLTP-mediated transfer and
liganding affinity of GLTP
We find that the interaction of GLTP with SLBs is very
weak, irrespective of the absence or presence of GM1, and
that GLTP does not perturb the morphology of the SLB.
Despite the weak and transient interaction, GM1 transfer
is efficient. These results are fully consistent with previous
reports by Rao et al. (34,55) on small unilamellar vesicles;
they had observed binding affinities between GLTP and
lipid membranes in the lower mM range.
Zhai et al. (36) reported KD¼ 4.75 1.7 mM for the inter-
action between GLTP and GM1, and similar values for
other GSLs. Considerably lower values have though also
been reported (35). Our result of 1.5 5 0.4 mM is of the
same order of magnitude as the value by Zhai et al. (36),
albeit in the range of good agreement. Both values were ob-
tained with very different analytical approaches, and we
cannot exclude that the small difference originates from
minor systematic errors in one of the techniques. In addi-
tion, we note that the value by Zhai et al. was derived
from micellar GM1 solutions whereas our study was based
on SLBs. The liganding affinity could well be affected by
the altered presentation of GM1.
Overall, the comparison of our data with the literature
(33,36) demonstrates that the efficiency and mechanism of
action of GLTP on SLBs is similar to that on vesicles.The asymmetric distribution of GM1 in SLBs
Our coincubation assays with EUVs containing the same
nominal amount of GM1 as the SLBs (Fig. 3 A) revealed
that GM1 distributes highly asymmetrically in silica-sup-
ported lipid bilayers, with ~85% of all GM1 residing in
the bulk-facing SLB leaflet, over the entire range of GM1
concentrations investigated (0–5 mol %). Our results extend
earlier reports that attractive or repulsive interactions
between specific lipids and the support can strongly modu-
late the interleaflet lipid distribution (3,22–24).
Shreve et al. (25) had previously reported GM1 enrich-
ment in the bulk-facing leaflet of silica-SLBs, although
the degree of asymmetry could not be quantified in absolute
terms. Both GM1 and silica carry negative charges, and their
mutual repulsion could be the driving force for the asym-
metric lipid distribution (25). Asymmetric distributions
have also been observed for mixtures of PC with other lipids
carrying charged headgroups, such as Texas red-labeled
phosphoethanolamine (25) or trimethylammonium-propane
(22) on silica or glass. For other charged lipids, such as
phosphatidylserine, symmetric lipid distributions were
though found in the presence of millimolar quantities of
calcium ions (3,10). In our case, we mixed 2 mM CaCl2
into the buffer to facilitate SLB formation (39) but typically
investigated GM1 transfer and CTB5 binding in EDTA-
containing buffer, and one may speculate that these subtleBiophysical Journal 99(9) 2947–2956
2954 Carton et al.changes in the buffer could affect the asymmetry. Compar-
ative measurements in the presence of calcium ions and
EDTA, respectively, within a few minutes after SLB forma-
tion, and after overnight incubation of the SLB in EDTA-
containing buffer, however, did not reveal any significant
change in CTB5 binding (data not shown). We note that
GM1 has a rather large headgroup of ~1 nm in extension
and, hence, steric constraints in the cleft between support
and membrane may also contribute to the asymmetry.CTB5 is a quantitative marker for accessible GM1
Fig. 3 A provides evidence that CTB5 binds with close-to-
maximal stoichiometry to GM1-containing SLBs as long
as CTB5 binding is not limited by space constraints on the
membrane surface. CTB5 can hence be employed as a quan-
titative probe for the presence of GM1 in the accessible
membrane leaflet up to concentrations of ~8 mol %. This
finding is not trivial and indeed remarkable, if one considers
that CTB5 pentamers bind in a multivalent manner to the
membrane surface.
In our assays, CTB5 was typically present in large excess.
Earlier work by Lauer et al. (47) indicated that excess CTB5
would compete for GM1, thereby limiting the average
number of GM1 molecules per pentamer. The authors put
forward a model that takes into account the ‘‘cross-linking’’
of up to five GM1 molecules by a CTB5 pentamer. From the
model, and the interaction parameters derived by Lauer
et al. (47), one would expect that each pentamer binds on
average to <1.7 GM1 molecules under the experimental
conditions that we have employed in our assays
(Fig. 3 C). Our data contradict this prediction and several
other implications of the model (see Fig. 3 C for details).
The measurements by Lauer et al. were performed at
GM1 concentrations %0.5 mol %, which is on the lower
limit of the detection range of our assay. We suggest that
the kinetic parameters derived by Lauer et al. cannot be
applied for higher GM1 concentrations. Interestingly, the
model appears to be consistent with our data, if the equilib-
rium cross-linking constant that describes how easily the
empty binding sites of CTB5 can be occupied by the later-
ally diffusing GM1 is increased by four orders of magnitude
(Fig. 3 C). This may imply that cross-linking is limited by
mass transport, i.e., the lateral diffusion of GM1 within
the SLB, rather than being kinetically limited, as proposed
earlier (47).
It has been reported previously that GM1 forms clusters
in SLBs of a similar lipid background (POPC instead of
DOPC) and on a similar surface (glass instead of silica)
and that the fraction of GM1 that is incorporated in these
clusters increases in a nonlinear fashion with increasing
GM1 proportion in the SLB (56). It is not unlikely that
similar clusters do also form under the conditions employed
by us. It appears that these clusters do not significantly
affect the binding stoichiometry.Biophysical Journal 99(9) 2947–2956CONCLUSIONS
We have demonstrated that GLTP is an efficient and robust
biochemical tool to quantitatively, specifically, and dynam-
ically modulate the glycosphingolipid content of supported
lipid membranes without affecting its overall morphology.
Owing to the importance of GSLs in modulating structure
and function of membranes and membrane proteins and
their selective distribution in membrane domains, this tool
may find widespread use in membrane research.
By exploiting an in situ combination of two mass-sensi-
tive and label free techniques (i.e., QCM-D and ellipsome-
try) and the unique capacity of GLTP to shuttle GSLs
between membrane compartments, we showed that GM1
distributes highly asymmetrically in silica-supported lipid
bilayers, with most of the ganglioside residing in the bulk-
facing leaflet. We do also find that CTB5 binds with close-
to-maximal stoichiometry to GM1 in SLBs over a large
range of GM1 concentrations, and quantified the liganding
affinity of GLTP for GM1.SUPPORTING MATERIAL
A scheme of typical steps in our interaction assays, details about the quan-
tification of the contribution of coupled solvent to the QCM-D response
upon CTB5 binding, expected QCM-D frequency shifts upon CTB5 binding
as a function of the GM1 content in the bulk-facing SLB leaflet, and
a detailed description of the quantitative assays for the binding of GM1
to GLTP are available at http://www.biophysj.org/biophysj/supplemental/
S0006-3495(10)01162-8.
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